Management of hematologic malignancies in pregnant women;Prise en charge des hemopathies malignes survenant au cours de la grossesse

Journal de Gynecologie Obstetrique et Biologie de la Reproduction

Volumn 25, Issue 6, 1996, Pages 602-607

  Maloisel, F ^a   Dreyfus, M ^a   Neuhart, D ^a   Ritter, J ^a   Oberling, F ^a  

^a HÔPITAL DE HAUTEPIERRE   (France)

Author keywords

acute leukemia; chemotherapy; chronic myeloid leukemia; Hodgkin's disease; non Hodgkin lymphoma; pregnancy; radiotherapy

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER CHEMOTHERAPY; FEMALE; HODGKIN DISEASE; HUMAN; LEUKEMIA; NONHODGKIN LYMPHOMA; PREGNANCY COMPLICATION; PREGNANCY TERMINATION; REVIEW; CANCER STAGING; FETOMATERNAL TRANSFUSION; LYMPHOMA; PATIENT CARE; PREGNANCY; PREGNANCY OUTCOME; TREATMENT OUTCOME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; FEMALE; HUMANS; LEUKEMIA; LYMPHOMA; MATERNAL-FETAL EXCHANGE; NEOPLASM STAGING; PATIENT CARE TEAM; PREGNANCY; PREGNANCY COMPLICATIONS, NEOPLASTIC; PREGNANCY OUTCOME; TREATMENT OUTCOME;

EID: 0029683684     PISSN: 03682315     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (49)

1. Nieminen V, Remes N. Malignancy during pregnancy. Acta Obstet Gynecol Scand 1970;49:315-8.
2. Silverberg E, Lubera J. Cancer statistics, 1986. CA 1986;36:9-25.
3. Haas JF. Pregnancy in association with a newly diagnosed cancer : a population-based epidemiologic assessment. Int J Cancer 1984; 34:229-35.
4. Sachs BP, Penzias AS, Brown DA, Driscoll SG, Jewett JF. Cancer-related maternal mortality in Massachusetts, 1954-1985. Gynecol Oncol 1990;36:395-400.
5. Ioachim HL, Moroson H. Lymphoma and pregnancy : clinical observations and experimental investigations. Leukemia 1994;8(suppl 1):S198-201.
6. Pirani BBK, Campbell DM, MacGillivray I. Plasma volume in normal first pregnancy. J Obstet Gynecol Br Commonwealth 1973;80:884-7.
7. Mucklow JC. The fate of drugs in pregnancy. Clin Obstet Gynecol 1986;13:161-75.
8. Powis G. Anticancer drug pharmacodynamics. Cancer Chemother Pharmacol 1985;14:177-83.
9. Wan SH, Huffman DH, Azarnoff DL et al. Effect of route of administration and effusions on methotrexate pharmacokinetics. Cancer Res 1974;34:3487-91.
10. Karp GI, Von Oeyen P, Valone F et al. Doxorubicin in pregnancy : possible transplacental passage. Cancer Treat Rep 1983;67:773-7.
11. Roboz J, Gleicher N, Wu N et al. Does doxorubicin cross the placenta ? Lancet 1979;i(no 11):1382-3.
12. Beeley L. Adverse effects of drugs in the first trimester of pregnancy. Clin Obstet Gynecol 1986;13:177-95.
13. Doll DC, Ringenberg QS, Yarbro JW. Antineoplasic agents and pregnancy. Sem Oncol 1989;16:337-46.
14. Avilles A, Diaz-Maqueo JC, Talavera A, Guzman R, Garcia EL. Growth and development of children of mothers treated with chemotherapy during pregnancy : current status of 43 children. Am J Hematol 1991;36:243-8.
15. Ward FT, Weiss RB. Lymphoma and pregnancy. Seminars Oncol 1989;16:397-409.
16. Barry RM, Diamond HD, Craver LF. Influence of pregnancy on the course of Hodgkin's disease. Am J Obstet Gynecol 1962;84:445-54.
17. Weisberger C, Gogel L, Teillet F. Problèmes gynéco-obstétriques au cours de la maladie de Hodgkin. Actual Hematol 1974;8:152-63.
18. Gobbi PG, Attardo-Parrinello G, Danesino M et al. Hodgkin's disease and pregnancy. Haematologica 1984;69:336-41.
19. Jouet JP, Buchert-Bouverne B, Fenaux P, Pollet JP, Simon M, Walter MP, Leroy JL, Puech F, Delecour M, Bauters F. Influence de la grossesse sur l'évolutivité de la maladie de Hodgkin ? Presse Med 1988;17:423-7.
20. Sweet DL. Malignant lymphoma : implications during the productive years and pregnancy. J Reprod Med 1976;77:198-208.
21. Straus DJ. Treatment of early stage Hodgkin's disease. Blood Rev 1993;7:34-42.
22. Thomas PRM, Peckham MJ. The investigation and management of Hodgkin's disease in pregnant patient. Cancer 1976;39:1443-51.
23. O'Dell RF. Leukemia and lymphoma complicating pregnancy. Clin Obstet Gynecol 1979;22:859-70.
24. Chouraqui A, Creuzillet C, Barrat H. Irradiation et grossesse. Rev Prat 1985;55:1395-401.
25. Nisce LZ, Tome MA, He S et al. Management of coexisting Hodgkin's disease and pregnancy. Am J Clin Oncol 1986;9:146-51.
26. Jacobs C, Donaldson SS, Rosenberg SA, Kaplan HS. Management of the pregnant patient with Hodgkin's disease. Ann Int Med 1981;95:669-75.
27. Aviles A, Diaz-Maqueo J, Torras V, Garcia EL, Guzman R. Non-Hodgkin lymphomas and pregnancy : presentation of 16 cases. Gynecol Oncol 1989;37:335-7.
28. Caliguiri MA, Mayer RJ. Pregnancy and leukemia. Sem Oncol 1989;16:388-96.
29. Catazarite VA, Fergusson JE. Acute leukemia and pregnancy : a review of management and outcome. Obstet Gynecol Surv 1984;39:663-78.
30. Hoelzer D. Acute lymphoblastic leukemia in adults: recent progress, future directions. Sem Hematol 1987;24:27-39.
31. Antunez de Mayolo J, Ahn YS, Temple JD, Harrington WJ. Spontaneous remission of acute leukemia after the termination of pregnancy. Cancer 1989;63:1621-3.
32. Cantini E, James B : Acute myelogenous leukemia in pregnancy. South Med J 1984;77:1050-2.
33. Doll DC, Ringenberg QS, Yarbro JW. Management of cancer during pregnancy. Arch Intern Med 1988;148:2058-64.
34. Reynoso EE, Huerta F. Acute leukemia and pregnancy. Fatal fetal outcome after exposure to idarubicin during the second trimester. Acta Oncol 1994;33:709-10.
35. Fenaux P, Le Deley MC, Castaigne S, Archimbaud E, Chomienne C, Linke H et al. Effect of all transretinoic acid and newly diagnosed acute promyelocytic leukemia. Results of a multicenter randomized trial. Blood 1993;82:3241-9.
36. Harrison P, Chipping P, Fothergill GA. Successful use of all-trans retinoic acid in acute promyelotic leukemia presenting during the second trimester of pregnancy. Br J Haematol 1994;86:691-2.
37. Stentoft J, Nielsen JL, Hvidman LE. All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy. Leukemia 1994;8:1585-8.
38. Bazarbashi MS, Smith MR, Karanes C, Zielinski I, Bishop CR. Successful management of Ph chromosome chronic myelogenous leukemia with leukapheresis during pregnancy. Am J Hematol 1991;38:235-7.
39. Patel M, Dukes IA, Hull JC. Use of hydroxyurea in chronic leukemia during pregnancy : a case report. Am J Obstet Gynecol 1991;165:565-6.
40. Baer MR, Ozer H, Foon KA. Interferon a therapy during pregnancy in chronic myelogenous leukemia and hairy cell leukemia. Br J Haematol 1992;81:167.
41. Crump M, Wang XH, Sermer M, Keating A. Successful pregnancy and delivery during alpha-interferon therapy for chronic myeloid leukemia. Am J Hematol 1992;40:238-9.
42. Reichel RP, Linkesh W, Schetitska D. Therapy with recombinant Interferon alpha 2c during unexpected pregnancy in a patient with chronic myeloid leukemia. Br J Haematol 1992;82:472.
43. Tefferi A, Silverstein MN, Hoagland HC. Primary thrombocythemia. Semin Oncol 1995;22:334-40.
44. Bokemeyer C, Schmoll HJ, Van Rhee J, Kuczyk M, Schuppert F, Poliwoda H. Long term gonadal toxicity after therapy for Hodgkin's and non-Hodgkin's lymphoma. Ann Hematol 1994;68:105-10.
45. Miller KD. Hodgkin's disease : impact on childbearing. J Perinatal Neonatal Nurs 1994;7:1-12.
46. Hudson MM, Greenwald C, Thompson E, Wilimas J, Marinas N, Fairclough D et al. Efficacy and toxicity of multiagents chemotherapy and low-dose involved-field radiotherapy in children and adolescents with Hodgkin's disease. J Clin Oncol 1993;11:100-8.
47. Aisner J, Wiernik PH, Pearl P. Pregnancy outcome in patients treated for Hodgkin's disease. J Clin Oncol 1993;11:507-12.
48. Whitehead E, Shalet SM, Blackledge G. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 1983;52:988-93.
49. Salooja N, Chatterjee R, McMillan AK, Kelsey SM, Newland AC, Milligan DW et al. Successful pregnancies in women following single autotransplant for acute myeloid leukemia with a chemotherapy ablation protocol. Bone Marrow Transplantation 1994;13:431-5.